No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Clinical Trials, Phase I as Topic*
-
Crizotinib
-
Humans
-
Immunotherapy
-
Neoplasms / drug therapy*
-
Protein Kinase Inhibitors / therapeutic use
-
Pyrazoles / therapeutic use
-
Pyridines / therapeutic use
Substances
-
Antineoplastic Agents
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Pyridines
-
Crizotinib